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Abstract: Ekki-Youketsu-Fusei-Zai (EYFZ), one of the Traditional Chinese Medicines (TCMs) is a mixture of six 
kinds of crude drugs. It was already found that an oral administration of EYFZ had a life-prolonging effect on tumor-
bearing mice and an inhibitory influence on tumor growth. To elucidate the mechanisms of these anti-tumor effects, 
we first investigated the effect of EYFZ on morphology and cytokine production of murine macrophage-like cell 
line, J774.1 cells. In this experiment, the addition of EYFZ (1.2mg crude drug/ml) to J774.1 culture induced the 
morphological change from round type to spread type, also the increase of their size. We next examined 6 kinds of 
cytokine mRNA expression by J774.1 cell in response to EYFZ-stimulation. RT-PCR revealed that both interleukin-12 
(IL-12)p35 and IL-12p40 mRNA expression were induced by EYFZ treatment. Moreover, EYFZ promoted the 
secretion of IL-12 from J774.1 cells. These results strongly suggest that EYFZ with some significant anti-tumor effect 
induces the functional activation of J774.1 cells.
Keywords: murine macrophage cell line J774.1, Traditional Chinese Medicine (TCM), Ekki-Youketsu-Fusei-Zai 
(EYFZ), morphological change, IL-12 mRNA expression, IL-12 production.
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Introduction
Macrophages are known to be activated in vitro 
by a variety of agents, leading to an increase of 
metabolism, syntheses and release of lysosomal 
enzyme, phagocytosis, and anti-mitotic or anti-tumor 
effects. Many of these agents are generally potent 
immunological adjuvants or immunopotentiators, some 
of which are natural products called biological response 
modifiers (BRM)1) and possess functions affecting 
immune system and host defense mechanisms. BRM 
also alters the host biological responses2), and is 
effective in suppressing tumor cells3). Among these 
products, bacterial lipopolysaccharides (LPS) is one of 
the strongest activators of macrophage4,5). To verify the 
mechanisms underlying the LPS action on macrophage, 
murine macrophage-like cell line J774.1 has been so far 
used in many investigations6-14).
Though one of BRMs, Traditional Chinese Medicine 
(TCM), is an undefined crude extract from a mixture of 
many plants, animals and minerals, the prescription is 
defined for each TCM. There have been many reports 
describing the biological actions of TCMs on immune 
responses in mammals15-21). Ekki-Youketsu-Fusei-Zai 
(EYFZ), one of the TCMs, is a mixture composed of 
extract of six kinds of crude drugs; Astragali radix, 
Zizyphy fructus, Amomi semen, Angelica radix, Cervi 
parvum cornu, and Rehmanniae radix. EYFZ has 
frequently been prescribed for the treatment of cancer 
patients in China. Recently, we demonstrated that an 
oral administration of EYFZ had a life-prolonging effect 
on tumor-bearing mice and an inhibitory influence on 
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tumor size22). However, the biological action of EYFZ 
on murine immune response in vitro has not been 
investigated.
Previously, we tried to examine the effects of oral 
administration of EYFZ on the functions of peritoneal 
macrophage in tumor-bearing BALB/c mice, it was 
difficult to get some effects of EYFZ on macrophage 
functions. For example, first, mice got weak after the 
implantation of colon-26 cell, and it was difficult to 
collect enough cells of resting macrophage without 
thiolycollate-stimulation. Secondly, since the 
thiolycollate itself strongly stimulated the resting 
peritoneal macrophage in tumor-bearing mice, we could 
not find any difference between the EYFZ-administrated 
and control mice on functions of peritoneal macrophage. 
Thirdly, J774.1 macrophage-like cell line is originated 
from the BALB/c mice and can be used for study 
of macrophage function in vitro and were also 
reported to show the same cytokine production as the 
macrophages23-26). That’s because, in the present study, 
we examined the effect of EYFZ on morphological 
changes and cytokine production of J774.1 in vitro to 
elucidate the mechanisms underlying the EYFZ action 
on immune responses.
Materials and Methods
Preparation of EYFZ EYFZ is a mixture of six 
kinds of crude drugs. All of the crude drugs were 
purchased from Tochimoto (Osaka, Japan). EYFZ 
(dose/person/day) was prepared as follows. First, a 
mixture of Astragali radix (10.0 g), Zizyphy fructus (5.0 
g), Amomi semen (5.0 g), Angelica radix (8.0 g), Cervi 
parvum cornu (5.0 g), and Rehmanniae radix (10.0) 
was added to 200 ml distilled water (DW) and soaked 
for 20 min at room temperature. Then, it was boiled 
for 30 min for extraction of effective substances, and 
the solution was centrifuged at 3000 rpm for 20 min. 
Finally, the supernatant was condensed to 43 ml (1 g 
crude drug/ml) by evaporation, and diluted with DW 
to desired concentrations.
Cell culture The murine macrophage-like cell line, 
J774.1, was obtained from Riken Cell Bank (RCB, 
Japan). The cells were maintained in 75 cm2 plastic 
culture flasks (Falcon) in RPMI-1640 medium (Roswell 
Park Memorial Institute) with kanamycin (5g/ml, 
Sigma) and 5 % fetal bovine serum. Cells were incubated 
at 37 ℃ in a humidified atmosphere containing 5 % CO2. 
Cells harvested by gentle scraping were passaged 
every 3-4 days by diluting 1:10 with fresh medium.
Observation of morphological changes of J774.1 
J774.1 cells were suspended in culture medium at 
a concentration of 5104 cells/ml, and 5 ml of cell 
suspension is plated in a 25 cm2 plastic culture flask 
(Falcon). The cells were incubated with 1.2 mg crude 
drug/ml of EYFZ, 10 ng/ml lipopolysaccaride (LPS) 
or culture medium only for 3, 6, 12 hrs at 37 ℃ in 5 % 
CO2 in air. After incubation, the cell morphology was 
observed under a phase-contrast microscope (model 
ND; Nikon, Tokyo, Japan), and photographed in 
random fields.
RT-PCR J774.1 cells were suspended in culture 
medium at a cell concentration of 5 104 cells/ml, 
and 5 ml of the cell suspension was plated in a 
25 cm2 plastic culture flask (Falcon). Cells were 
cultured for 24 and 48 hrs in the presence of 1.2 mg 
crude drug/ml of EYFZ, 10 ng/ml LPS or culture 
medium only. After incubation, cells were harvested by 
scraping, and quickly frozen and stored at 80 ℃ . Total 
cellular RNAs were extracted from 1106 J774.1 cells 
by the use of RNessy Mini Kit (QIAGEN). The first 
strand cDNA synthesis was performed by incubating 
0.5 g of either RNA sample in a total reaction 
volume of 20 l containing 2 l of 10 mM dNTP 
mixture, 2 l of 10mM oligo-(dT), 10X reaction 
buffer for AMV reverse transcriptase, and 4 units 
(U) of AMV reverse transcripase XL (TOYOBO, 
Japan) at 42 ℃ for 1hr. The sequence of oligo-(dT) was 
5’-GCTCTAGATTTTTTTTTTTTTTTTTTTTTT-3’. Two 
l of the first strand synthesis production and 2 l 
each of 10 mM oligonucleotide primers (Table 1) were 
added to the reaction mixture (100 l) containing 8 l 
of 10 mM dNTP mixture, 8 l of 25 mM MgCl2, 10X Ex 
TaqTM buffer, and 4 units (U) of Ex TaqTM (TAKARA, 
Japan). Each reaction was carried out as follows; IL-1; 
denaturing at 94 ℃ for 5 min, 30 cycles of amplification 
(94 ℃ for 1 min, 58 ℃ for 2 min, and 72 ℃ for 3 min) 
and extension at 72 ℃ for 10 min. IL-12p40 and IFN-; 
denaturing at 94 ℃ for 5 min, 30 cycles of amplification 
(94 ℃ for 40 sec, 60 ℃ for 20 sec, and 72 ℃ for 49 sec) 
and extension at 72 ℃ for 5min. IL-12p35, TNF- and 
-actin; denaturing at 94℃ for 5 min, 30 cycles of 
amplification (94 ℃ for 1 min, 55 ℃ for 1 min, and 72 ℃ 
for 2 min) and extension at 72 ℃ for 7 min.
Measurements of IL-12 IL-12 production by J774.1 
cells was assayed by using ELISA kits OptEIATM 
Mouse IL-12 (p70) Set (PHARMINGEN) according to 
the protocols by manufacturer. Cells were cultured for 
24, 48 and 72 hrs in the presence of 0.15 mg/ml, 1.2 
mg/ml and 3.6 mg crude drug/ml of EYFZ, 10 ng/ml 
LPS or culture medium only. After incubation, the culture 
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supernatants were collected and stored at 80 ℃ until 
use.
Statistical Analysis A statistical significance of 
difference between the control and experimental group 
was analyzed by Students t-test.
Results
Morphological changes caused by EYFZ To 
elucidate the effect of EYFZ on J774.1 cells, 
morphological changes were observed under a phase-
contrast microscope after incubation with EYFZ for 3, 6, 
12 hrs (Fig. 1). EYFZ at 1.2 mg crude drug/ml caused 
great changes in their size and shapes; while J774.1 
cells in the presence of EYFZ became spread and/or 
elongated with numerous vacuoles and granules inside, 
the cells without EYFZ mostly remained round with 
some protrusions. We counted the number of spread 
and round cells in each condition (Fig. 2), and also 
measured the diameter of each cell (Fig. 3). As shown 
in Fig. 2, the number of round type cells in all these 
conditions after incubation for 3 hrs was over 70 % 
respectively, while the number of spreads types of cells 
with EYFZ and that with LPS for 12 hrs significantly 
increases compared with that of control. Similarly, the 
diameter of most cells after incubation with EYFZ and 
also with LPS for 3 hrs was below 20 m which was 
almost similar to that of the control, while after 12hrs 
over 70 % of the cells stimulated with EYFZ and also 
those with LPS had diameter over 21 m. Because the 
growth of J774.1 cells stimulated with EYFZ stopped, 
the number of the cells after incubation with EYFZ for 
12hrs was smaller than the control. These results show 
that J774.1 cells change greatly in shape and size in 
response to EYFZ, suggesting that EYFZ induced the 
activation of J774.1 cells.
The effect of EYFZ on the expression of cytokine 
mRNAs The cytokine mRNA expression of J774.1 cells 
treated with or without EYFZ was investigated. The 
gel electrophoretic patterns of the RT-PCR products of 
IL-1 , IL-12p35, IL-12p40, IFN-, TNF- and -actin are 
presented in Fig. 4. The expression level of IL-12p35 and 
IL-12p40 was induced in J774.1 cells after 12hrs and 24hrs 
of the treatment with EYFZ, though the expression of 
-actin, a house keeping gene, was almost constant in 
each sample. We could not find any differences of other 
cytokine expression between treated cells and untreated 
cells.
EYFZ stimulates J774.1 cells to produce IL-12 
We next examined whether this increased expression 
of IL-12 induced by EYFZ occurs at the protein level. 
After J774.1 cells were incubated with 0.15 mg/ml, 1.2 
mg/ml and 3.6 mg crude drug/ml of EYFZ for 24, 
48 and 72 hrs, IL-12 in the culture supernatants were 
assayed by ELISA. As shown in Fig. 5, IL-12 secreted 
from J774.1 cells stimulated with EYFZ in the culture 
supernatants was significantly higher in concentration 
compared to that of the control.
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Discussion
In this study, we examined the activation of murine 
macrophage-like cell line J774.1 after EYFZ-treatment, 
and the results suggest that J774.1 cells were activated by 
EYFZ and expressed IL-12. We also showed that J774.1 
cells stimulated with EYFZ secreted IL-12 in the culture 
supernatant. J774.1 cells are originated from BALB/c 
mice and have almost the same characterizations with the 
in vivo macrophages in the immunological function23-26), 
so it seems to be considered that these results will be 
applicable to the in vivo macrophages.
Macrophages are involved at almost all stages of the 
immune response and play a role in the initial response 
to microbial infection before T- and B cell immunity 
is mobilized. Mechanisms by which macrophages act 
as effector cells in a host defense system include both 
intracellular and extracellular cytokine secretion activities. 
Thus, we investigated here whether EYFZ could stimulate 
the secretion of cytokine from J774.1.
As shown in this study, EYFZ was able to induce 
IL-12 production by J774.1. IL-12 has recently been 
brought into focus as an effector molecule to enhance 
immunity by murine macrophages27-29). Production of 
IL-12 by macrophages can be induced by interaction with 
activated T cells, which provide costimulatory signals via 
molecules such as CD40 ligand. These signals appear to 
be essential, because their inhibition can abrogate IL-12 
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Fig. 2. The time course of morphological change after EYFZ stimulation.  
Effects of EYFZ, LPS, and culture medium only on the morphology of J774.1 after incubation for 3, 6, and 12 hrs. 
Open bars show the % of the number of oval type cells (in Fig. 1) and hatched bars show the % of the number of 
spread type cells (in Fig. 1). Values represent the mean  S.D. of duplicate experiment.
Fig. 1. Morphological changes of J774.1 in response to EYFZ. The cells were treated 
without (A), with (B) 1.2 mg crude drug/ml EYFZ, or with (C) 10 ng/ml LPS. Each 
picture shows the feature of the cells after stimulation for 3 hrs (A-1, B-1 and C-1), 6 
hrs (A-2, B-2 and C-2), and 12 hrs (A-3, B-3 and C-3). In A-3 and B-3 oval type cells 
(arrowheads) and spread type (arrows) are abundant, respectively. The photographs 
were taken as described in the text, and representative fields are shown. Bar, 25 m.
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Fig. 3. The time course of size change after EYFZ stimulation.
Effects of EYFZ, LPS, and culture medium only on the size of J774.1 incubation for 3, 6, and 12 hrs. Open bars 
show the % of the number of small cells (diameter was below 20 m), hatched bars and solid bars show the % of 
the number of large cells (diameter were over 21 m to 30 m and over 31 m, respectively).
Fig. 5. The secretion of IL-12 from J774.1 stimulated with EYFZ. 
The secretion of IL-12 from J774.1 was examined after incubation for 24, 48, and 72 hrs. J774.1 cells (1106 
cells/ml) were cultured in the presence of EYFZ (0.15 mg/ml, 1.2 mg/ml and 3.6 mg crude drug/ml) (hatched 
bars), LPS (10 ng/ml) (solid bars), or control (culture medium only). Values represent the mean  S.D. of four 
independent experiments.
Fig. 4. The effects of EYFZ on the expression of cytokine mRNAs. 
J774.1 cells stimulated with EYFZ or LPS in culture were assayed 
for IL-1, IL 12p35, IL-12p40, IFN-, TNF- and -actin mRNA 
by RT-PCR. The results are for a typical example of repeated 
experiments.
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production. IL-12 exerts multiple effects on T and NK 
cells including the augmentation of IFN- production, 
proliferation, and cytotoxic activity, and also plays an 
important role to determine a Th1/Th2 balance30). IL-12 
is a heterodimeric cytokine composed of disulfide linked 
p40 and p35 subunits; both subunits have to be expressed 
within the same cell to produce biologically active 
p70 heterodimer31). It has been shown that p40 mRNA 
expression is up-regulated in the cells producing IL-12, 
whereas p35 mRNA is constitutively expressed in various 
cells32). As shown in Fig. 4, the expressions of IL-12p35 
and IL-12p40 were induced similarly as assessed at 12 
hrs and 24 hrs after the treatment with EYFZ. Moreover, 
our results of ELISA show that this increased expression 
of IL-12p35 and IL-12p40 induced by EYFZ occurs at the 
protein level.
The anti-tumor effects of EYFZ in colon-26 implanted 
mice were shown in our previous report22), and it was 
reported that IL-12 has anti-tumor effect33-36) and a 
powerful anti-tumor activity in mice against 17 different 
lines of transplantable murine tumors, including 
carcinomas, sarcomas, melanomas and lymphomas37). 
IL-12 is much more effective in anti-tumor effect than 
are other cytokines, such as IL-2 and IFN-α, and is 
effective at the doses with much lower toxicity. In 
our study, relationship is unclear between the effects 
of EYFZ on anti-tumor and enhancement of NK 
function in vivo and activation of macrophage like 
cell line J774.1 in vitro. However, some papers 
showed that components of crude drugs of EYFZ 
include polysaccharide38-43), which can activate the 
function of macrophage. Thus, whether or not oral 
administration of EYFZ can induce macrophages to 
produce endogenetic IL-12 is not demonstrated now. 
So, this elucidation needs more study in future.
Conclusively, we have found that EYFZ markedly 
activates J774.1 to produce IL-12, which is potentially 
an immune enhancer. The mechanism of this activating 
effect on J774.1 by EYFZ is still unclear. In order 
to study this mechanism, the isolation and chemical 
characterization of the active compounds from EYFZ 
are needed.
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中国の伝統的漢方薬である「益気養血扶正剤」（オ
ウギ，ジュクジオウ，トウキ，ジュクシャ，タイソ
ウ，ロクジョウの 6種類から構成される：以下EYFZ
と略す）が抗腫瘍活性を示すことが担癌マウスの延命
効果並びにNK活性促進から判明したので，本研究で
は第 2としてマクロファージ機能への影響を知る目的
で，同じBALB/c糸マウス由来のマクロファージ細胞
株J774.1細胞を用いてEYFZの影響をIn vitro で追究し
た．J774.1の培養液に種種の濃度のEYFZを添加した，
細胞形態の変化を細胞機能活性化の視点で経時的に顕
微鏡観察するとともに，マクロファージ産生サイトカ
インであるインターロイキン -12（IL-12）並びに腫瘍
壞死因子（TNF-α）の産生への影響をRT-PCR法及び
ELISA法によって調べた．実験の結果，EYFZを添加
すると，非添加群よりも早く細胞の大きさが増し，球
状タイプよりも伸展タイプの数が増加することが判明
した．一方，RT-PCR法でサイトカインmRNA発現を
調べると，特にIL-12p35及びIL-12p40がEYFZによっ
て強く誘導された．またJ774.1の培養液中IL-12産生
をELISA法で検討した結果，実際にIL-12がEYFZ存在
下で強く産生されることがわかった．以上の結果か
ら，EYFZにはマウスのマクロファージ細胞株J774.1
の機能を活性化する作用があり，細胞性免疫機能を亢
進することが強く示唆された．
中国の伝統的漢方薬「益気養血扶正剤」の抗腫瘍活性と免疫細胞機能に及ぼす影響
2.�マウスのマクロファージ細胞株J774.1 の形態変化の誘導とIL-12 産生の促進
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